Evaluation of the Performance of AIR OPTIX® COLORS

NCT01338402 — Not applicable, Completed, 47 participants, CIBA VISION

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT01338402
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, single group, masking: single
Enrollment47 (Actual)
SponsorCIBA VISION (Industry); collaborators: University of Waterloo
ConditionsMyopia
InterventionsLotrafilcon B contact lens, Lotrafilcon B contact lens with color, Phemfilcon A contact lens with color (Device)
Datesstart 2011-04-01, primary completion 2012-03-01, completion 2012-03-01, first posted 2011-04-19, last updated 2014-02-20
Locations1 site in Canada

Related Papers Related Patents Related Grants Related Experts
All trials for Myopia All trials of Lotrafilcon B contact lens All trials of Lotrafilcon B contact lens with color

-Summary

The purpose of this study was to assess the ocular response to and performance of the cosmetically printed silicone hydrogel contact lens AIR OPTIX® COLORS compared to FRESHLOOK® COLORBLENDS.

Expand all sections  ·  Collapse all

+Detailed description

The study was conducted in two phases. Phase 1 was an adaptation phase where participants wore AIR OPTIX® AQUA contact lenses bilaterally (same product in both eyes) on a daily wear basis for 1 week. In Phase 2, participants wore AIR OPTIX® COLORS and FRESHLOOK® COLORBLENDS contact lenses contralaterally (different product in each eye) on a daily wear basis for 4 weeks.

+Arms and interventions

ArmTypeInterventionsDescription
AIR OPTIX® AQUAOtherDevice: Lotrafilcon B contact lensLotrafilcon B contact lenses worn in both eyes on a daily wear basis for one week in Phase 1.
AIR OPTIX® COLORSExperimentalDevice: Lotrafilcon B contact lens with colorLotrafilcon B contact lens with color randomly assigned to one eye, with phemfilcon A contact lens with color in the fellow eye for contralateral wear. Both products worn on a daily wear basis for 4 weeks in Phase 2. A replacement phemfilcon A lens was dispensed at the Week 2 visit.
FRESHLOOK® COLORBLENDSActive comparatorDevice: Phemfilcon A contact lens with colorPhemfilcon A contact lens with color randomly assigned to one eye, with lotrafilcon B contact lens with color in the fellow eye for contralateral wear. Both products worn on a daily wear basis for 4 weeks in Phase 2. A replacement phemfilcon A lens was dispensed at the Week 2 visit.
  • Lotrafilcon B contact lens (Device), also known as AIR OPTIX® AQUA: Silicone hydrogel contact lens
  • Lotrafilcon B contact lens with color (Device), also known as AIR OPTIX® COLORS: Silicone hydrogel contact lens with color
  • Phemfilcon A contact lens with color (Device), also known as FRESHLOOK® COLORBLENDS: Hydrogel contact lens with color

+Outcome measures

Primary outcomes

  • Visual Acuity [Phase 2: Up to Week 4]
  • Corneal Staining [Phase 2: Up to Week 4]
  • Conjunctival Staining [Phase 2: Up to Week 4]
  • Surface Regularity Index (SRI) [Up to Phase 2, Week 4]
  • Surface Asymmetry Index (SAI) [Up to Phase 2, Week 4]
  • Subjective ratings [Phase 2: Up to Week 4]

+Eligibility

Sex: All, ages: 17 Years to any

Inclusion Criteria:

* Full legal capacity to volunteer;
* Read and sign information and consent letter;
* Willing and able to follow instructions and maintain the appointment schedule;
* Ocular examination in the last two years;
* Currently wears soft contact lenses on a daily wear basis;
* Contact lens prescription between -1.50 diopters and -5.00 diopters;
* Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

* Any ocular disease;
* Any systemic condition that may affect a study outcome variable;
* Any systemic or topical medications that may affect ocular health;
* Known sensitivity to the diagnostic pharmaceuticals used in the study;
* Unable to achieve an acceptable fit with the study lenses;
* Anisometropia >1.00 diopter or astigmatism >0.75 diopter;
* Use of lubricating/rewetting eye drops.
* Other protocol-defined exclusion criteria may apply.

+Locations (1)

FacilityCityCountryStatus
Centre for Contact Lens Research, University of WaterlooWaterloo, OntarioCanada

+Investigators